Literature DB >> 20048677

Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department.

David F Gaieski1, Mark E Mikkelsen, Roger A Band, Jesse M Pines, Richard Massone, Frances F Furia, Frances S Shofer, Munish Goyal.   

Abstract

OBJECTIVE: To study the association between time to antibiotic administration and survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department.
DESIGN: Single-center cohort study.
SETTING: The emergency department of an academic tertiary care center from 2005 through 2006. PATIENTS: Two hundred sixty-one patients undergoing early goal-directed therapy.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Effects of different time cutoffs from triage to antibiotic administration, qualification for early goal-directed therapy to antibiotic administration, triage to appropriate antibiotic administration, and qualification for early goal-directed therapy to appropriate antibiotic administration on in-hospital mortality were examined. The mean age of the 261 patients was 59 +/- 16 yrs; 41% were female. In-hospital mortality was 31%. Median time from triage to antibiotics was 119 mins (interquartile range, 76-192 mins) and from qualification to antibiotics was 42 mins (interquartile range, 0-93 mins). There was no significant association between time from triage or time from qualification for early goal-directed therapy to antibiotics and mortality when assessed at different hourly cutoffs. When analyzed for time from triage to appropriate antibiotics, there was a significant association at the <1 hr (mortality 19.5 vs. 33.2%; odds ratio, 0.30 [95% confidence interval, 0.11-0.83]; p = .02) time cutoff; similarly, for time from qualification for early goal-directed therapy to appropriate antibiotics, a significant association was seen at the < or =1 hr (mortality 25.0 vs. 38.5%; odds ratio, 0.50 [95% confidence interval, 0.27-0.92]; p = .03) time cutoff.
CONCLUSIONS: Elapsed times from triage and qualification for early goal-directed therapy to administration of appropriate antimicrobials are primary determinants of mortality in patients with severe sepsis and septic shock treated with early goal-directed therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048677     DOI: 10.1097/CCM.0b013e3181cc4824

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  270 in total

1.  Hospital-based acute care use in survivors of septic shock.

Authors:  Alexandra Ortego; David F Gaieski; Barry D Fuchs; Tiffanie Jones; Scott D Halpern; Dylan S Small; S Cham Sante; Byron Drumheller; Jason D Christie; Mark E Mikkelsen
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

2.  Junior doctors are not good at recognizing and treating sepsis: a validated suggestion for improvement.

Authors:  J M Brostoff; E K Potter; A Kapila
Journal:  Clin Med (Lond)       Date:  2010-10       Impact factor: 2.659

3.  Dosing of Appropriate Antibiotics and Time to Administration of First Doses in the Pediatric Emergency Department.

Authors:  Abby M Bailey; Maria Stephan; Kyle A Weant; Stephanie Baker Justice
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

4.  Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED.

Authors:  Geoffrey E Hayden; Rachel E Tuuri; Rachel Scott; Joseph D Losek; Aaron M Blackshaw; Andrew J Schoenling; Paul J Nietert; Greg A Hall
Journal:  Am J Emerg Med       Date:  2015-08-28       Impact factor: 2.469

5.  Use of Individual Pharmacokinetics to Improve Time to Therapeutic Vancomycin Trough in Pediatric Oncology Patients.

Authors:  Calvin L Miller; S Alexander Winans; John J Veillette; Steven C Forland
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

6.  A cohort study on protocol-based nurse-led out-patient management of post-chemotherapy low-risk febrile neutropenia.

Authors:  Fiona Lim Mei Ying; Maria Choy Yin Ping; Macy Tong; Elaine Yim Pik Yan; Tracy Lui Siu Yee; Lam Yuk Ting; Anita Lo Wing Sim; Lui Cheuk Yu; Bosco Lam Hoi Shiu; Ashley Cheng Chi Kin
Journal:  Support Care Cancer       Date:  2018-03-20       Impact factor: 3.603

7.  Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.

Authors:  Iris K Minichmayr; André Schaeftlein; Joseph L Kuti; Markus Zeitlinger; Charlotte Kloft
Journal:  Clin Pharmacokinet       Date:  2017-06       Impact factor: 6.447

8.  Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.

Authors:  Kevin Meyer; Maressa Santarossa; Larry H Danziger; Eric Wenzler
Journal:  Hosp Pharm       Date:  2017-03

9.  Importance of Pharmacy Involvement in the Treatment of Sepsis.

Authors:  Joseph B Cavanaugh; Jesse B Sullivan; Nicole East; Jessica N Nodzon
Journal:  Hosp Pharm       Date:  2017-03

10.  Evaluation of the nanosphere verigene gram-positive blood culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients.

Authors:  Stacy G Beal; Jane Ciurca; Geremy Smith; Jeffrey John; Francesca Lee; Christopher D Doern; Rita M Gander
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.